Advertisement
 
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

New Model for Parkinson's Disease

June 27, 2012 11:31 am | News | Comments

Researchers have detailed animal experiments showing how misfolded proteins travel from sick to healthy cells spreading Parkinson's disease through the brain.

TOPICS:

Siemens Opens Factory Outside Chicago

June 27, 2012 11:24 am | News | Comments

Siemens Healthcare opened a refurbished systems factory in Wood Dale, Ill. The facility will refurbish a broad array of previously owned medical imaging systems.

TOPICS:

Watson Pushing for Generic Pristiq

June 27, 2012 11:15 am | News | Comments

Watson Pharmaceuticals Inc. is challenging a patent supporting Pfizer Inc.'s antidepressant Pristiq and has requested marketing approval to produce a generic version.

TOPICS:
Advertisement

Alexza Files New Marketing Application

June 27, 2012 11:07 am | News | Comments

Alexza Pharmaceuticals Inc. has filed a new marketing application for Adasuve, a drug designed to treat acute agitation caused by schizophrenia or bipolar disorder.

TOPICS:

FDA Nears Trokendi Approval

June 27, 2012 11:01 am | News | Comments

Supernus Pharmaceuticals Inc. announced that regulators have moved closer to granting final approval to its potential epilepsy treatment Trokendi XR.

TOPICS:

Suits Filed Against Pain Pill Distributors

June 27, 2012 10:57 am | by Lawrence Messina | News | Comments

West Virginia's attorney general filed lawsuits against 14 drug distributors, alleging their negligent practices have helped fuel the state's pain pill abuse epidemic.

TOPICS:

Roche Slashing 1,000 Jobs

June 27, 2012 10:47 am | by Linda A. Johnson | News | Comments

Swiss drugmaker Roche Holding AG said it will close its former U.S. headquarters, a sprawling facility where the groundbreaking drugs Valium and interferon were invented.

TOPICS:

AstraZeneca Granted Buyout Option

June 27, 2012 10:41 am | News | Comments

Drugmakers Merck & Co. and AstraZeneca PLC have amended their U.S. partnership to give AstraZeneca a 2014 buyout option that could cost more than $400 million.

TOPICS:
Advertisement

Particle Size Analyzer

June 26, 2012 12:08 pm | Product Releases | Comments

The  SALD-2300 laser diffraction particle size analyzer from Shimadzu Scientific Instruments measures wet or dry materials to ensure outstanding product quality in the pharmaceutical space.

TOPICS:

Separation Columns

June 26, 2012 12:05 pm | Drug Discovery & Development, Drug Discovery & Development | Product Releases | Comments

Thermo Fisher Scientific Inc. expanded its portfolio of Accucore columns with a range of columns for biomolecule separations.

TOPICS:

Flow Cytometry Laser

June 26, 2012 11:57 am | Product Releases | Comments

A 561 nm laser option is now available for Gallios flow cytometers from Beckman Coulter Life Sciences. This laser allows researchers to analyze a greater range of fluorescent proteins.

TOPICS:

Cholesterol Combo May Be More Effective

June 26, 2012 11:42 am | News | Comments

A study has found that intensive cholesterol therapy involving a combination of drugs for 20 years may be more effective over the long run than taking a single statin medication.

TOPICS:

HPV, Sun Can Be Dangerous Mix

June 26, 2012 11:39 am | News | Comments

Researchers have found that having antibodies for cutaneous types of HPV, coupled with sun exposure, can act "synergistically" in the development of skin cancer.

TOPICS:

Quotient, Capsugel Begin Formulation Partnership

June 26, 2012 11:17 am | News | Comments

Quotient Clinical and Capsugel have announced a collaboration to enable the rapid development and clinical assessment of lipid-based formulations.

TOPICS:

Watson to Become Third-Largest Generic Maker

June 26, 2012 11:04 am | News | Comments

Watson Pharmaceuticals Inc. is taking out a $1.8 billion five-year loan to help fund its purchase of Actavis Group. The deal will push Watson to third place on the list of largest generic drugmakers.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading